Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine: Results From an 8-week, Multicenter, Double-blind, Placebo-controlled Trial

NCT02989727 is registered in ClinicalTrials.gov with University of Saskatchewan as lead sponsor.

NCT NCT02989727
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02989727 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Melancholic Symptoms in Bipolar Depression and Responsiveness to Lamotrigine: Results From an 8-week, Multicenter, Double-blind, Placebo-controlled Trial
Lead sponsor
University of Saskatchewan
Phase
Phase 4
Overall status
Completed
Start date
November 30, 2003
Completion date
December 31, 2017
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, bipolar disorder, depression, lamotrigine, melancholia